Back to results
US 2022/0023431 A1Published application
Proteolysis-targeting chimeric molecules (protacs) that induce degradation of indoleamine 2,3-dioxygenase (ido) protein
AssigneeNorthwestern University
InventorsGary E. Schiltz, Derek A. Wainwright
Life of this patent
Estimating the term…
Abstract
Disclosed are proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of IDO protein. The disclosed PROTACs typically include a first targeting moiety that binds to IDO (MIDO). The first targeting moiety typically is linked via a bond or a linker (L) to a second targeting moiety that binds to an E3 ubiquitin ligase (ME3). As such, the disclosed PROTACS may be described as having a formula MIDO-L-ME3 or ME3-L-MIDO.
Claims20
A molecule having a formula:
- MIDO-L-ME3, wherein MIDO is a moiety that binds to indoleamine 2,3-dioxygenase (IDO), L is a bond or a linker covalently attaching MIDO and ME3, and ME3 is a moiety that binds to an E3 ubiquitin ligase.
Dependencies are inferred from the claim text.